Management of patients with resistant hypertension: current treatment options. - Wikidata - wikimedia - TriplyDB

Management of patients with resistant hypertension: current treatment options.

Management of patients with resistant hypertension: current treatment options.

http://www.wikidata.org/entity/Q37304418

about

Genetics of resistant hypertension: a novel pharmacogenomics phenotype Resistant hypertension: an approach to management in primary care.Characterization and history of arterial hypertension leading to inpatient treatment.Resistant hypertension in type 2 diabetes: prevalence and patients characteristics.Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status.Vitamin D deficiency and risk of cardiovascular diseases: a narrative review.Exercise as a tool for hypertension and resistant hypertension management: current insights

P2860

Q26851506-429549AD-9139-4F38-A8DF-6F2A8073E4FA Q35534677-AE79839C-C5E3-4BA6-BF6B-A0AF3CFC4412 Q36173470-421D6845-CE70-458B-BB04-AE7F024ADE34 Q36247763-51D241AC-FF26-418E-B42D-62A201DE2EFB Q42262245-D008C08F-6CCB-4B7B-92C6-66F029B7E83C Q55497443-48C480B7-A588-4EBC-8ED3-3DA2177D1896 Q57071962-49A1B83D-C007-47CD-BD72-3E4C4BD36CDB

P2860

Management of patients with resistant hypertension: current treatment options.

http://www.wikidata.org/entity/Q37304418

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Management of patients with resistant hypertension: current treatment options.

@en

Management of patients with resistant hypertension: current treatment options.

@nl

type

label

Management of patients with resistant hypertension: current treatment options.

@en

Management of patients with resistant hypertension: current treatment options.

@nl

prefLabel

Management of patients with resistant hypertension: current treatment options.

@en

Management of patients with resistant hypertension: current treatment options.

@nl

P1433

Q37304418-5473CFA3-A323-4B95-ADB7-1CD4E6CC5236

P1476

Q37304418-875B741C-5B61-4B4F-B4AD-754E55B7BCCC

P2093

Q37304418-7B90D2C2-6034-4450-9E88-1BD65653FDC4

Q37304418-CA0C70B8-F9D2-4BA4-827C-C0D1DD332955

Q37304418-F657B45F-2CD1-4F6C-9D71-03CD9229BD31

P2860

Q37304418-00DF8E77-35ED-45F6-AD2E-E2EFBEB870F4

Q37304418-00DFBEAA-E235-4BA3-9E2E-1DCD1B60886F

Q37304418-039B5DBC-1BF3-4A11-9F29-55682FBDB794

Q37304418-03F5BF60-8795-47F4-902A-4A93A0EC00E5

Q37304418-04F16D47-B3EA-4381-9A1C-37EC0A82240F

Q37304418-08CC96F0-37A0-466A-A4D8-35942BC3A549

Q37304418-0E253384-E983-4648-BAB1-54248C92AB5B

Q37304418-12E5439A-DC67-422D-ABED-77E5BFB03083

Q37304418-132ED1FA-3741-4B66-AA0D-3341F62E7B97

Q37304418-13CD5886-31FB-4456-9B60-BDAD30D1942B

P304

Q37304418-B1E80FA6-EC5F-4612-B88C-CE07782FE47B

P31

Q37304418-63A7B65C-BEB7-4EBE-B7EE-E1518099C133

P356

Q37304418-EF306B74-1819-4DAD-B13D-B9557F3CE6D5

P407

Q37304418-A851BFEF-9898-4EB3-8943-54A15BE1D844

P478

Q37304418-0C9A1FFE-8CAA-4B77-8C59-40928C91CB01

P577

Q37304418-E97DB37C-A2C6-4AB0-A719-CAC9F59BB5DA

P698

Q37304418-0001FC92-A5CE-4C06-817A-43C7E7FC8208

P921

Q37304418-B146F0AB-50D9-4E36-B8C7-F38D32B275D1

P932

Q37304418-F0BD0186-70B3-4CA9-A8F3-FFF6B6DE435F

P356

P1433

Integrated Blood Pressure Control

P1476

Management of patients with resistant hypertension: current treatment options.

@en

P2093

David A Calhoun

http://www.w3.org/2001/XMLSchema#string

Nilay Kumar

http://www.w3.org/2001/XMLSchema#string

Tanja Dudenbostel

http://www.w3.org/2001/XMLSchema#string

P2860

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

High prevalence of unrecognized sleep apnoea in drug-resistant hypertension

Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation

Current opinions in renovascular hypertension

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

The occurrence of sleep-disordered breathing among middle-aged adults

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study

P304

139-151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IBPC.S33984

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24231917

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

3826290

http://www.w3.org/2001/XMLSchema#string